Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Amr M Shaker"'
Autor:
Amr M Shaker, Eman El Mohamed, Hussein H Samir, Mahmoud M Elnokeety, Hossam A Sayed, Tarek A Ramzy
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 29, Iss 3, Pp 531-539 (2018)
Renal ischemia/reperfusion injury is a major cause of acute kidney injury (AKI). The lack of early biomarkers for predicting AKI has hampered our ability to initiate preventive and therapeutic measures in an opportune way. Fibroblast growth factor 23
Externí odkaz:
https://doaj.org/article/daf27d80d17b43fa8ee1b83e3c144dff
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 29, Iss 3, Pp 105-111 (2017)
Background Diabetic nephropathy is the principal single cause of end-stage renal disease. The most important parameter in the clinical evaluation of kidney function is the glomerular filtration rate (GFR), which is generally accepted as the best over
Externí odkaz:
https://doaj.org/article/55f780349ca143adae780330d333e1aa
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 28, Iss 5, Pp 1196-1200 (2017)
Externí odkaz:
https://doaj.org/article/11f70c32cd3e47cf8fe4c4c0504afad5
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 28, Iss 2, Pp 52-59 (2016)
Background Fibroblast growth factor 23 (FGF23), a novel bone-derived hormone that inhibits phosphate reabsorption and calcitriol production by the kidney, has uncovered primary regulatory pathways and new systems biology governing bone mineralization
Externí odkaz:
https://doaj.org/article/bdffc217e1054b49baa02b1316af6ee9
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 35, Iss 1, Pp 1-13 (2023)
Abstract Background Diabetic nephropathy (DN) is one of the major causes of ESKD, and its complications are characterized by proteinuria, decreased glomerular filtration, and renal fibrosis resulting in the deterioration of renal functions, so early
Externí odkaz:
https://doaj.org/article/d5555e3578e848edad2acd514fa630ed
Autor:
Amr M. Shaker, Nahal K. Rakha, Amal M. R. El-Shehaby, Tarek Ramzy, Wael M. Hamza, Mohamed M. Elkhatib
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 34, Iss 1, Pp 1-16 (2022)
Abstract Background Renal tubulointerstitial fibrosis is a structural marker and prominent pathological characteristic of chronic progressive kidney disease, fibroblast growth factor-2 (FGF2) is a key fibrogenic cytokine that is likely to be involved
Externí odkaz:
https://doaj.org/article/c8492ba2898643e09541869fbbc4a08b
Publikováno v:
Open Access Macedonian Journal of Medical Sciences. 9:328-335
BACKGROUND: Early renal graft dysfunction is a major problem in the early post-transplantation period and is considered a major cause of graft loss. Clinical diagnosis based on the clinical criteria alone is unreliable; therefore, biopsy remains the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2de346858b89ee144f0bc7df984488ef
https://doi.org/10.3889/oamjms.2021.6081
https://doi.org/10.3889/oamjms.2021.6081
Publikováno v:
Therapeutic Apheresis and Dialysis. 22:666-673
Therapeutic plasma exchange is used in treating different immunological and non-immunological diseases. We analyzed the outcome of 308 patients treated by 1783 membrane plasma exchange sessions from January 2011 until January 2017 at Cairo University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3655f78eedead649972a62387fa79bb5
https://doi.org/10.1111/1744-9987.12710
https://doi.org/10.1111/1744-9987.12710
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 30, Iss 4, Pp 803-811 (2019)
Rheumatoid arthritis (RA) is accompanied by a variety of nephropathies. It is often difficult to distinguish between disease-associated and drug-associated renal diseases. Three hundred and seventy-six RA patients with renal involvement were included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86dae1295c46896cf9d4aacdf17b0d8c
https://pubmed.ncbi.nlm.nih.gov/35017360
https://pubmed.ncbi.nlm.nih.gov/35017360
Autor:
Hossam A. Sayed, Mahmoud M Elnokeety, Amr M. Shaker, Eman El. Mohamed, Tarek Ramzy, Hussein H. Samir
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 29, Iss 3, Pp 531-539 (2018)
Renal ischemia/reperfusion injury is a major cause of acute kidney injury (AKI). The lack of early biomarkers for predicting AKI has hampered our ability to initiate preventive and therapeutic measures in an opportune way. Fibroblast growth factor 23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6501c0ee367cf72fb4e7dfb9bf78ca87
https://doi.org/10.4103/1319-2442.235180
https://doi.org/10.4103/1319-2442.235180